Tracking the Pivotal Point of Cardinal Health (CAH): Q1 Revenue Rises 22% to $64 Billion - Higher Annual Forecast Creates Positive Sentiment!
Reading Time: 1 minute
Cardinal Health experienced a significant stock surge on October 30, 2025, due to excellent results for the first quarter of fiscal year 2026. The company, an essential link in healthcare distributing pharmaceuticals and medical products, reported a revenue increase of 22% to $64 billion. The Pharma and Specialty Solutions segment showed particularly strong performance with a growth of 23%. The adjusted earnings per share significantly exceeded expectations, rising by 36% to $2.55. The positive momentum led management to raise the annual forecast...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
